v3.25.2
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023 0      
Beginning balance at Dec. 31, 2023 $ 0      
Ending balance (in shares) at Mar. 31, 2024 0      
Ending balance at Mar. 31, 2024 $ 0      
Beginning balance (in shares) at Dec. 31, 2023   4,569,900    
Beginning balance at Dec. 31, 2023 66,913 $ 1 $ 311,256 $ (244,344)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of early exercise of common stock options (in shares)   1,266    
Vesting of early exercise of common stock options 34   34  
Stock-based compensation 1,258   1,258  
Net loss (12,111)     (12,111)
Ending balance (in shares) at Mar. 31, 2024   4,571,166    
Ending balance at Mar. 31, 2024 $ 56,094 $ 1 312,548 (256,455)
Beginning balance (in shares) at Dec. 31, 2023 0      
Beginning balance at Dec. 31, 2023 $ 0      
Ending balance (in shares) at Jun. 30, 2024 0      
Ending balance at Jun. 30, 2024 $ 0      
Beginning balance (in shares) at Dec. 31, 2023   4,569,900    
Beginning balance at Dec. 31, 2023 66,913 $ 1 311,256 (244,344)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (23,314)      
Ending balance (in shares) at Jun. 30, 2024   4,572,432    
Ending balance at Jun. 30, 2024 $ 44,148 $ 1 311,805 (267,658)
Beginning balance (in shares) at Mar. 31, 2024 0      
Beginning balance at Mar. 31, 2024 $ 0      
Ending balance (in shares) at Jun. 30, 2024 0      
Ending balance at Jun. 30, 2024 $ 0      
Beginning balance (in shares) at Mar. 31, 2024   4,571,166    
Beginning balance at Mar. 31, 2024 56,094 $ 1 312,548 (256,455)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of early exercise of common stock options (in shares)   1,266    
Vesting of early exercise of common stock options 33   33  
Stock-based compensation (776)   (776)  
Net loss (11,203)     (11,203)
Ending balance (in shares) at Jun. 30, 2024   4,572,432    
Ending balance at Jun. 30, 2024 $ 44,148 $ 1 311,805 (267,658)
Beginning balance (in shares) at Dec. 31, 2024 21,157      
Beginning balance at Dec. 31, 2024 $ 25,106      
Increase (Decrease) in Temporary Equity [Roll Forward]        
Conversion of Series A redeemable convertible preferred stock to common stock (in shares) (21,157)      
Conversion of Series A redeemable convertible preferred stock to common stock $ (25,106)      
Ending balance (in shares) at Mar. 31, 2025 0      
Ending balance at Mar. 31, 2025 $ 0      
Beginning balance (in shares) at Dec. 31, 2024 4,829,035 4,829,035    
Beginning balance at Dec. 31, 2024 $ 25,649 $ 1 322,782 (297,134)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Conversion of Series A redeemable convertible preferred stock to common stock (in shares)   21,157,000    
Conversion of Series A redeemable convertible preferred stock to common stock 25,106 $ 2 25,104  
Issuance of common stock for vesting of restricted stock units (in shares)   17,909    
Vesting of early exercise of common stock options (in shares)   422    
Vesting of early exercise of common stock options 12   12  
Stock-based compensation 1,204   1,204  
Net loss (14,112)     (14,112)
Ending balance (in shares) at Mar. 31, 2025   26,004,366    
Ending balance at Mar. 31, 2025 $ 37,859 $ 3 349,102 (311,246)
Beginning balance (in shares) at Dec. 31, 2024 21,157      
Beginning balance at Dec. 31, 2024 $ 25,106      
Ending balance (in shares) at Jun. 30, 2025 0      
Ending balance at Jun. 30, 2025 $ 0      
Beginning balance (in shares) at Dec. 31, 2024 4,829,035 4,829,035    
Beginning balance at Dec. 31, 2024 $ 25,649 $ 1 322,782 (297,134)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss $ (28,845)      
Ending balance (in shares) at Jun. 30, 2025 26,160,206 26,160,206    
Ending balance at Jun. 30, 2025 $ 24,652 $ 3 350,628 (325,979)
Beginning balance (in shares) at Mar. 31, 2025 0      
Beginning balance at Mar. 31, 2025 $ 0      
Ending balance (in shares) at Jun. 30, 2025 0      
Ending balance at Jun. 30, 2025 $ 0      
Beginning balance (in shares) at Mar. 31, 2025   26,004,366    
Beginning balance at Mar. 31, 2025 37,859 $ 3 349,102 (311,246)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock related to ATM, net of commissions and issuance costs (in shares)   155,840    
Stock-based compensation 1,526   1,526  
Net loss $ (14,733)     (14,733)
Ending balance (in shares) at Jun. 30, 2025 26,160,206 26,160,206    
Ending balance at Jun. 30, 2025 $ 24,652 $ 3 $ 350,628 $ (325,979)